Nurse Practitioner, Acute Care · Fargo, ND
NPI
1194175422
Since 2016
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
801 Broadway N
Fargo, ND, 58102
Phone (701) 234-2516
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
570 services
Medicare patients, 2024
364
Average age 77
Drug cost, 2024
$3.5M
6,650 prescriptions
Company payments, 2025
$315
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica A Silveri was code 99214 (office e&m - established), 422 times for 282 patients. In total Jessica A Silveri billed 570 services in 18 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 422 | 282 | $55.07 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 44 | 37 | $50.83 | $2,237 |
| 99231 Hospital E&M - Subsequent | Facility | 40 | 30 | $30.19 | $1,208 |
| 99233 Hospital E&M - Subsequent | Facility | 13 | 13 | $76.45 | $994 |
By year: 2022 $40K for 735 services; 2023 $31K for 536 services; 2024 $31K for 570 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80048 Clinical Chemistry | 31 | 13 | $8.42 | $261 |
Medicare prescription drug claims, 2024
In 2024, the drug Jessica A Silveri prescribed most often to Medicare patients was Metoprolol Succinate, with 664 prescriptions and refills. In total Jessica A Silveri wrote 6,650 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 664 | 1,573 | 215 | $14K |
| Furosemide Generic | 648 | 1,344 | 216 | $4,114 |
| Spironolactone Generic | 634 | 1,527 | 211 | $4,539 |
| Carvedilol Generic | 448 | 1,043 | 154 | $4,713 |
| Entresto Sacubitril/Valsartan | 423 | 646 | 100 | $415K |
| Eliquis Apixaban | 311 | 474 | 69 | $261K |
| Losartan Potassium Generic | 309 | 820 | 104 | $3,750 |
| Lisinopril Generic | 278 | 682 | 95 | $2,180 |
| Torsemide Generic | 210 | 437 | 73 | $8,845 |
| Jardiance Empagliflozin | 208 | 373 | 49 | $166K |
| Atorvastatin Calcium Generic | 195 | 436 | 59 | $2,588 |
| Potassium Chloride Generic | 166 | 324 | 54 | $4,998 |
| Rosuvastatin Calcium Generic | 162 | 410 | 57 | $1,815 |
| Bumetanide Generic | 161 | 311 | 56 | $10K |
| Bisoprolol Fumarate Generic | 161 | 273 | 26 | $3,956 |
Brand drugs: 1,379 claims; generic drugs: 5,271 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica A Silveri $315 ($315 in general payments such as food, travel and fees) from 3 companies. The largest payer was CVRx, Inc. with $138.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.